Clinical Trial: A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07107373) titled 'A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US' on July 30.

Brief Summary: The purpose of this study is to evaluate the real-world safety and effectiveness of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) initiated on mavacamten at certain high volume HCM centers in the US

Study Start Date: Dec. 22, 2023

Study Type: OBSERVATIONAL

Condition: Obstructive Hypertrophic Cardiomyopathy (oHCM)

Intervention: DRUG: Mavacamten

According to the product label

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Bristol-Myers Squibb

Disclaimer: Curated...